DAVID WHITESIDE: Open Payments
NPI 1003205626 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$994 in 51 payments from 17 companies in 2025. Trend: 2023 $2,108 · 2024 $1,724 · 2025 $994
Food & beverage: $994
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $154 |
| Astellas Pharma US Inc | 5 | $103 |
| Verona Pharma, Inc. | 5 | $93 |
| Dexcom, Inc. | 3 | $92 |
| Lilly USA, LLC | 4 | $80 |
| Novo Nordisk Inc | 5 | $72 |
| Amgen Inc. | 4 | $66 |
| ABBVIE INC. | 3 | $61 |
| Eisai Inc. | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
Products named: Veozah, NURTEC ODT, Ohtuvayre, Dexcom G6 Transmitter, Ozempic, Leqembi, MOUNJARO, VRAYLAR.
Industry payments across SC — which companies pay providers there.
